Red Cells with Paroxysmal Nocturnal Hemoglobinuria-phenotype in Patients with Acute Leukemia

References

• Men, S. and larva, H. (1998) "Complement regulation", Vox Sang. 2\(Suppl. 2 , 291–302.
   Google Scholar
• Frank, M.M. (1987) "Complement in the pathophysiology of human disease", N. Engl. J. Med. 316, 1525–1530.
   PubMed Web of Science ®Google Scholar
• Lublin, D.M. and Atkinson, J.P. (1989) "Decay accelerating factor: biochemistry, molecular biology and function", Ann. Rev. Immunol. 7, 35–58.
   PubMed Web of Science ®Google Scholar
• Walport, M.J. (2001) "Complement. First of two parts", N. Engl. J. Med. 344, 1058–1066.
   PubMed Web of Science ®Google Scholar
• Luzzatto, L. and Bessler, M. (1996) "The dual pathogenesis of PNH", Curr. Opin. Hematol. 3, 101–110.
   PubMedGoogle Scholar
• Karadimitris, A. and Luzzatto, L. (2001) "The cellular pathogenesis of paroxysmal nocturnal haemoglobinuria", Leukemia 15, 1148–1152.
   PubMed Web of Science ®Google Scholar
• Tremml, G., Karadimitris, A. and Lizzatto, L. (1998) "Paroxysmal nocturnal hemoglobinuria: learning about PNH cells from patients and mice", Haema 1, 12–20.
   Google Scholar
• Holt, D.S., Botto, M., Bygrave, A.E., Hanna, S.M., Walport, M.J. and Morgan, B.P. (2001) "Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria", Blood 98, 442–449.
   PubMed Web of Science ®Google Scholar
• Rosse, W.F. (2001) "New insights into paroxysmal nocturnal hemoglobinuria", Curr. Opin. Hematol. 8, 61–67.
   PubMed Web of Science ®Google Scholar
• Dunn, D.E., Tanawattanacharoen, P., Boccuni, P., Nagakura, S., Green, S.W., Kirby, M.R., Rosenfeld, S. and Young, N.S. (1999) "Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes", Ann. Intern. Med. 131, 401–408.
   PubMed Web of Science ®Google Scholar
• Meletis, J. and Terpos, E. (2001) "Paroxysmal nocturnal haemoglobinuria: clinical presentation and association with other haematological disorders", Haema 4, 79–88.
   Google Scholar
• Meletis, J., Terpos, E., Samarkos, M., Meletis, C., Konstantopoulos, K., Komninaka, V., Apostolidou, E., Benopoulou, O., Korovesis, K., Mavrogianni, D., Variami, E., Yataganas, X. and Loukopoulos, D. (2001) "Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anemia, myelodysplastic syndromes and myeloproliferative disorders", Haematologia 31, 7–16.
   PubMedGoogle Scholar
• Meletis, J., Terpos, E., Samarkos, M., Meletis, C., Apostolidou, E., Komninaka, V, Korovesis, K., Mavrogianni, D., Boutsis, D., Variami, E., Viniou, N., Konstantopoulos, K. and Loukopoulos, D. (2001) "Detection of CD55 and/or CD59 deficient red cell populations in patients with lymphoproliferative syndromes", Hematol. J. 2, 33–37.
   PubMedGoogle Scholar
• Meletis, J., Terpos, E., Samarkos, M., Meletis, C., Apostolidu, E., Komninaka, V, Korovesis, K., Anargyrou, K., Benopoulou, O., Mavrogianni, D., Variami, E., Viniou, N. and Konstantopoulos, K. (2002) "Detection of CD55 and/or CD59 deficient red cell populations in patients with plasma cell dyscrasias", Int. J. Hematol., 75, 40–44.
   PubMed Web of Science ®Google Scholar
• Hara, T., Kojima, A., Fukuda, H., Masaoka, T., Fukumori, Y., Matsumoto, M. and Seya, T. (1992) "Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies", Br. J. Haematol. 82, 368–373.
   PubMed Web of Science ®Google Scholar
• Seya, T., Tejima, H., Fukuda, H., Hara, T., Matsumoto, M., Hatanaka, M., Sugita, Y. and Masaoka, T. (1993) "Acute promyelocytic leukaemia with CD59 deficiency", Leuk. Res. 17, 895–896.
   PubMed Web of Science ®Google Scholar
• Guc, D., Canpinar, H., Kucukaksu, C. and Kansu, E. (2000) "Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies", Fur. J. Haematol. 64, 3–9.
   PubMed Web of Science ®Google Scholar
• Grimwade, D., Walker, H., Harrison, G., Oliver, F., Chatters, S., Harrison, C.J., Wheatley, K., Burnett, A.K. and Gold-stone, A.H. (2001) "The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukaemia (AML): analysis of 1065 patients entered into the UK Medical Research Council AML11 trial", Blood 98, 1312–1320.
   PubMed Web of Science ®Google Scholar
• Nilsson, B., Hagstrom, U., Englund, A. and Safwenberg, J. (1993) "A simplified assay for the specific diagnosis of Paroxysmal Nocturnal Hemoglobinuria: Detection of DAF (CD55)- and HRF20 (CD59)- erythrocytes in microtyping cards", Vox Sang. 64, 43–46.
   PubMed Web of Science ®Google Scholar
• Meletis, J., Michali, E., Samarkos, M., Konstantopoulos, K., Meletis, C., Terpos, E., Tsimberidou, A., Chandrinou, E., Viniou, N., Rombos, Y., Pangalis, GA., Yataganas, X. and Loukopoulos, D. (1997) "Detection of "PNH Red Cell" populations in hematological disorders using the sepha-cryl gel test micro typing system", Leuk. Lymphoma 28, 177–182.
   PubMed Web of Science ®Google Scholar
• Harris, J.W., Koscick, R., Lazarus, H.M., Eshleman, J.R. and Medof, M.E. (1999) "Leukemia arising out of paroxysmal nocturnal hemoglobinuria", Leuk. Lymphoma 32, 401–426.
   PubMed Web of Science ®Google Scholar
• Stafford, HA., Nagarajan, S., Weinberg, J.B. and Medof, M.E. (1995) "PIG-A, DAF and proto-oncogene expression in paroxysmal nocturnal haemoglobinuria-associated acute myelogenous leukaemic blasts", Br. J. Haematol. 89, 72–78.
   PubMed Web of Science ®Google Scholar
• Kwong, Y.L., Lee, C.P., Chan, T.K. and Chan, T.C. (1994) "Flow cytometric measurement of glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria", Am. J. Clin. Pathol. 102, 30–35.
   PubMed Web of Science ®Google Scholar
• Sun, X., Funk, CD., Deng, C., Sahu, A., Lambris, J.D. and Song, W.C. (1999) "Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting", Proc. Natl Acad. Sci. USA 96, 628–633.
   PubMed Web of Science ®Google Scholar
• Hatanaka, M., Seya, T., Matsumoto, M., Hara, T., Nonaka, M., Inoue, N., Takeda, J. and Shimizu, A. (1996) "Mechanisms by which the surface expression of the glycosyl-phosphatidyl-inositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines", Biochem. J. 314, 969–976.
   PubMed Web of Science ®Google Scholar
• Seya, T., Hara, T., Matsumoto, M. and Akedo, H. (1990) "Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down regulated during cell differen-tiation", J. Immunol. 145, 238–245.
   PubMed Web of Science ®Google Scholar
• Araten, D., Nafa, K., Pakdeesuwan, K. and Luzzatto, L. (1999) "Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals", Proc. Natl Acad. Sci. USA 96, 5209–5214.
   PubMed Web of Science ®Google Scholar
• Yamaguchi, M., Machii, T., Azenishi, Y., Nishimura, J., Shibano, M., Kanakura, Y. and Kitani, T. (2000) "Detection of small population of CD59-deficient erythrocytes in patients with aplastic anemia or myelodysplastic syn-dromes and normal individuals", Blood Cells Mol. Dis. 26, 247–254.
   PubMed Web of Science ®Google Scholar
• Rawstron, AC., Rollinson, S.J., Richards, S., Short, M.A., English, A., Morgan, G.J., Hale, G. and Hillmen, P. (1999) "The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment", Br. J. Haematol. 107, 148–153.
   PubMed Web of Science ®Google Scholar